Silab has announced Senevisium (INCI: Not Provided), a natural, anti-aging active ingredient obtained from Ginkgo biloba, with properties for reactivating the natural elimination of senescent fibroblasts by the immune system.
Senevisium also protects the skin from the effects of immunoevasive senescent fibroblasts on matrix synthesis and epidermal renewal.
Related: Silab Asserts Company Independence, Adapts Governance
In vitro and in vivo modeling studies by the company revealed the accentuation of the immunoevasion mechanism at the level of the skin after the age of 60, inducing profound changes (wrinkles, dull complexion, loss of elasticity and senescence spots).
Tested at 2% in white volunteers, it was unanimous that Senevisium made their skin firmer and their complexion lighter and more uniform after 28 days of treatment.
